Heinz Reichmann Selected Research

ropinirole (Requip)

6/2015	A Pilot Prospective, Multicenter Observational Study of Dopamine Agonist Withdrawal Syndrome in Parkinson's Disease.
5/2011	Long-term, open-label study of once-daily ropinirole prolonged release in early Parkinson's disease.
1/2011	Sleep Duration and "on" Time during Different Periods of the Day and Night in Patients with Advanced Parkinson's Disease Receiving Adjunctive Ropinirole Prolonged Release.
12/2009	Transdermal delivery of dopamine receptor agonists.
1/2007	Valvular heart disease in Parkinson's disease patients treated with dopamine agonists: a reader-blinded monocenter echocardiography study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Heinz Reichmann Research Topics

Disease

78	Parkinson Disease (Parkinson's Disease) 10/2022 - 10/2002
19	Stroke (Strokes) 07/2021 - 10/2010
13	Dyskinesias (Dyskinesia) 01/2022 - 05/2006
11	Ischemic Stroke 01/2021 - 12/2009
5	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2022 - 03/2011
5	Lymphoma (Lymphomas) 12/2020 - 12/2003
5	Disease Progression 10/2020 - 08/2013
4	Pain (Aches) 10/2021 - 06/2011
4	Tremor (Tremors) 01/2016 - 01/2003
4	Anhedonia 06/2015 - 01/2003
3	Synucleinopathies 10/2022 - 01/2017
3	Sleep Apnea Syndromes (Sleep Apnea) 01/2021 - 08/2013
3	Deglutition Disorders (Dysphagia) 01/2021 - 10/2012
3	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 08/2012
3	Hematoma 10/2019 - 02/2015
3	Cerebral Hemorrhage 10/2019 - 02/2015
3	Hepatolenticular Degeneration (Wilson's Disease) 01/2019 - 09/2006
3	Parkinsonian Disorders (Parkinsonism) 04/2013 - 09/2006
3	Mitochondrial Diseases (Mitochondrial Disease) 07/2011 - 03/2007
3	Dementia (Dementias) 07/2010 - 10/2006
2	Hallucinations (Hallucination) 10/2022 - 01/2016
2	Myasthenia Gravis 01/2022 - 12/2021
2	Dystonia (Limb Dystonia) 10/2021 - 10/2019
2	Alcoholism (Alcohol Abuse) 11/2020 - 12/2019
2	Leukocytosis (Pleocytosis) 10/2020 - 01/2018
2	Inflammation (Inflammations) 01/2020 - 01/2010
2	Peripheral Nervous System Diseases (PNS Diseases) 12/2019 - 03/2011
2	Anosmia 06/2017 - 08/2016
2	Orthostatic Hypotension (Postural Hypotension) 01/2017 - 02/2010
2	Friedreich Ataxia (Friedreich's Ataxia) 04/2016 - 03/2011
2	Sleepiness 01/2016 - 08/2006
2	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 01/2016 - 06/2015
2	Cognitive Dysfunction 03/2011 - 09/2008
2	Hypercholesterolemia 11/2010 - 12/2009
2	Neoplasms (Cancer) 07/2010 - 12/2009
2	Heart Valve Diseases (Valvular Heart Disease) 01/2007 - 08/2006
1	Diarrhea 10/2022
1	Chronic Disease (Chronic Diseases) 12/2021

Drug/Important Bio-Agent (IBA)

15	Levodopa (L Dopa)FDA LinkGeneric 01/2022 - 10/2002
13	Dopamine Agonists (Dopamine Agonist)IBA 01/2016 - 10/2002
11	Dopamine (Intropin)FDA LinkGeneric 01/2022 - 01/2003
10	Biomarkers (Surrogate Marker)IBA 02/2021 - 04/2013
6	opicaponeIBA 10/2022 - 07/2017
6	Pharmaceutical PreparationsIBA 01/2021 - 08/2006
6	alpha-SynucleinIBA 07/2020 - 09/2008
6	Pramipexole (Mirapex)FDA LinkGeneric 06/2015 - 01/2003
5	ropinirole (Requip)FDA LinkGeneric 06/2015 - 01/2007
4	EnzymesIBA 01/2022 - 11/2003
4	AnticoagulantsIBA 01/2019 - 02/2015
4	Cabergoline FDA LinkGeneric 06/2015 - 01/2007
3	salicylhydroxamic acid (SHAM)IBA 01/2021 - 06/2011
3	RotenoneIBA 01/2021 - 01/2010
3	oxidized low density lipoproteinIBA 01/2020 - 12/2009
3	N(4)-oleylcytosine arabinosideIBA 01/2019 - 02/2016
3	Monoamine Oxidase (MAO)IBA 01/2018 - 09/2008
3	Carbolines (Beta-Carbolines)IBA 06/2011 - 08/2006
2	entacapone (Comtan)FDA Link 10/2022 - 02/2012
2	Caffeine (No Doz)FDA LinkGeneric 05/2022 - 01/2022
2	rotigotine FDA Link 01/2021 - 07/2010
2	Cytarabine (Cytosar-U)FDA LinkGeneric 12/2020 - 02/2010
2	Methotrexate (Mexate)FDA LinkGeneric 12/2020 - 02/2010
2	Proteins (Proteins, Gene)FDA Link 10/2020 - 07/2011
2	LipidsIBA 01/2020 - 12/2019
2	SynucleinsIBA 01/2019 - 01/2017
2	CopperIBA 01/2019 - 09/2006
2	Vitamin K FDA Link 01/2019 - 02/2016
2	ElementsIBA 01/2017 - 07/2011
2	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2017 - 02/2014
2	IronIBA 04/2016 - 03/2011
2	Dopamine Receptors (Dopamine Receptor)IBA 01/2016 - 10/2006
2	Fluoxetine (Prozac)FDA LinkGeneric 10/2015 - 08/2015
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 10/2015 - 08/2015
2	amsonic acid (DAS)IBA 06/2015 - 01/2007
2	Retinaldehyde (Retinal)IBA 05/2013 - 12/2009
2	fluorodopa F 18IBA 05/2013 - 08/2011
2	NeurotoxinsIBA 06/2011 - 06/2010
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 09/2008 - 10/2006
2	Dopamine Agents (Dopaminergic Agents)IBA 12/2007 - 08/2006
2	Pergolide (Permax)FDA Link 01/2007 - 08/2006
2	Antidepressive Agents (Antidepressants)IBA 10/2006 - 01/2003
2	budipineIBA 10/2006 - 05/2006
1	Tolcapone (Tasmar)FDA Link 10/2022
1	catechol (pyrocatechol)IBA 10/2022
1	Theophylline (Theon)FDA LinkGeneric 05/2022
1	XanthineIBA 05/2022
1	Adenosine A2 Receptor AntagonistsIBA 05/2022
1	TheobromineIBA 05/2022
1	Nicotine FDA Link 01/2022
1	Cholinergic ReceptorsIBA 12/2021

Therapy/Procedure

33	Therapeutics 10/2022 - 01/2003
8	Drug Therapy (Chemotherapy) 12/2020 - 12/2003
6	Deep Brain Stimulation 01/2022 - 08/2006
5	Activities of Daily Living (ADL) 01/2021 - 01/2003
4	Blood Component Removal (Apheresis) 01/2020 - 12/2009
3	Aftercare (After-Treatment) 10/2021 - 06/2011
3	Radiotherapy 02/2010 - 12/2003
2	Tracheostomy 01/2022 - 08/2017
2	Artificial Respiration (Mechanical Ventilation) 01/2022 - 08/2017
2	Secondary Prevention 07/2021 - 01/2016
2	Combination Drug Therapy (Combination Chemotherapy) 02/2010 - 02/2009